Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Real World Study of Paxlovid for the Treatment of Hospitalized Patients Confirmed With COVID-19

NCT05387369 is registered in ClinicalTrials.gov with Huashan Hospital as lead sponsor.

NCT NCT05387369
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05387369 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Real World Study of Paxlovid for the Treatment of Hospitalized Patients Confirmed With COVID-19
Lead sponsor
Huashan Hospital
Phase
Observational
Overall status
Recruiting
Start date
March 21, 2022
Completion date
March 30, 2027
Enrollment
2,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19